Literature cited
B. Alberts, D. Bray, J. Lewis, et al., Molecular Biology of the Cell [Russian translation], Vol. 2, Moscow (1987), pp. 103–110.
Ibid., p. 205.
Ibid., pp. 268–269, 275–276.
European Patent No. 302,744. IPC CO7 239-36. Published August 7, 1987.
G. Alunnibistocchi, P. L. Orvietani, A. Ricci, et al., Farmaco.,45, No. 5, 499–509 (1990).
R. Andreesen, J. Osterholz, G. A. Luckenbuch, et al., J. Nat. Cancer Inst.,72, 53–59 (1984).
R. Andreesen and V. Giese, Lipids,22, No. 11, 836–841 (1987).
R. Andreesen and P. G. Munder, Platelet-Activation Factor and Cell Immunology: New Trends in Lipid Mediator Research, P. Braquet (ed.), Vol. 2, Basel (1988), pp. 16–29.
R. Andreesen, Progress in Biochemical Pharmacology, Vol. 22, Biologically Active Lipids, K. K. Carroll (ed.) Basel (1988), pp. 118–131.
G. W. Basill and T. M. Dexter, Biochem. Pharmacol.,38, No. 2, 374–377.11 (1989).
G. W. Basill and T. M. Dexter, Cancer Res.,50, No. 23, 7505–7512 (1990).
W. E. Berdel, M. Fromm, U. Fink, et al., ibid.,43, No. 11, 5538–5543 (1983).
W. E. Berdel, R. Andreesen, and P. G. Munder, Phospholipids and Cellular Regulation, J. F. Kuo (ed.), Boca Raton (1985), pp. 41–73.
W. E. Berdel and P. G. Munder, Platelet Activating Factor and Related Lipid Mediators, F. Snyder (ed.), New York (1987), pp. 449–467.
W. E. Berdel and S. Okamoto, Keio J. Med.,39, No. 2, 75–78 (1990).
M. R. Berger and D. Schmaehl, Lipids,22, No. 11, 935–942 (1987).
H. Brachwitz, P. Langen, D. Arndt, and I. Fichtner, Ibid., pp. 897–903.
H. Brachwitz, P. Langen, G. Dube, et al., Chem. Phy. Lipids.,54, No. 2, 89–98 (1990).
S. C. Crumpton, B. Goz, and K. S. Ishaq, Anticancer Res.,8, 1361–1366 (1988).
L. W. Daniel, L. A. Etkin, B. T. Morrison, et al., Lipids.,22, No. 11, 851–855 (1987).
L. Diomede, A. Bizzi, A. Magistrelli, et al., Int. J. Cancer,46, No. 2, 341–346 (1990).
C. Dive, J. V. Watson, and P. Workman, Cancer Res.,51, No. 3, 799–806 (1991).
S. Domhauser, W. E. Berdel, H. D. Schick, et al., Lipids,22, No. 11, 911–915 (1987).
E. A. M. Fleer, C. Unger, D. J. Kim, and H. Eibl., Ibid., pp. 856–861.
M. Fromm, W. E. Berdel, H. D. Schick, et al., Ibid., pp. 916–918.
J. Hafmann, F. Veberall, L. Posch., et al., Ibid.,24, No. 4, 312–317 (1989).
D. B. J. Herrman and H. A. Neumann, Ibid.,22, No. 11, 955–957 (1987).
C. Hochhuth, D. Berkovic, H. Eibl, et al., J. Cancer Res. Clin. Oncol.,16, No. 5, 459–466 (1990).
W. J. Houlihan, M. L. Lee, P. G. Munder, et al., Lipids.,22, No. 11, 884–890 (1987).
J. Koffing, C. Unger, and H. Eibl., Ibid., pp. 831–835.
H. Kosano, Y. Yasutomo, N. Kugai, et al., Cancer Res.,50, No. 11, 3172–3175 (1990)
L. S. Kucera, N. Lyer, E. Leake, et al., AIDS Res. Hum. Retrovirus,6, No. 4, 491–501 (1990).
I. Kudo, S. Nojima, H.-W. Chang, et al., Lipids,22, No. 11, 862–867 (1987).
Ch.-S. Lai, J. Joseph, C. C.-Y. Shih, Biochem. Biophys. Res. Commun.,160, No. 3, 1189–1195 (1989).
X. M. Lazenby, M. G. Thompson, and J. A. Hickman, Cancer Res.,50, No. 11, 3327–3330 (1990).
G. H. Leder, H. H. Fiebig, E. Wallbrecher, et al., Lipids.,22, No. 11, 958–961 (1987).
Y. Masuzawa, T. Sugiura, H. Sprecher, and K. Waku, Biochim. Biophys. Acta,1005, 1–12 (1989).
M. Modofell, R. Andreesen, W. Pahlke, et al., Cancer Res.,39, 4681–4686 (1979).
S. Morris-Natschke, J. R. Surles, L. W. Daniel, et al., J. Med. Chem.,29, 2114–2117 (1986).
Y. Nokagava, T. Sugiura, and K. Waku, Biochem. Biophys. Acta,833, No. 2, 323–329 (1985).
A. Noseda, M. E. Berens, C. Piantadosi, and E. J. Modest, Lipids,22, No. 11, 878–883 (1987).
A. Noseda, P. L. Godwin, and E. J. Modest, Biochim. Biophys. Acta,945, No. 1, 92–100 (1988).
K. Oishi, B. Zheng, J. F. White, et al., Biochem. Biophys. Res. Commun.,157, No. 3, 1000–1006 (1988).
H. D. Schick, W. E. Berdel, M. Fromm, et al., Lipids,22, No. 11, 904–910 (1987).
M. J. Seewald, R. A. Olsen, I. Sehgal, et al., Cancer Res.,50, No. 15, 4458–4463 (1990).
F. Snyder and C. Snyder, Progress in Biochemical Pharmacology, K. K. Carroll, ed., Vol. 10, Basel (1975), pp. 1–41.
F. Snyder, T. Ch. Lee, and M. L. Blank, Ann. N. Y. Acad. Sci.,568, 35–43 (1989).
G. A. M. Stallberg, Acta Chem. Scand.,44, No. 4, 368–376 (1990).
J. Storch and P. G. Munder, Lipids,22, No. 11, 813–819 (1987).
G. A. Storme, E. A. Bruneel, D. C. Achallier, et al., Ibid., pp. 847–850.
T. Sugiura, N. Sekiguchi, Y. Nakagawa, and K. Waku, Ibid., No. 8, pp. 583–595.
T. Sugiura and K. Waku, Platelet Activating Factor and Related Lipid Mediators, F. Snyder, ed., New York (1987), pp. 55–85.
J. E. Talmadge, M. Schneider, B. Lens, et al., Lipids,22, No. 11, 871–877 (1987).
K. Ukawa, E. Imamiya, H. Yamamoto, et al., Chem. Pharm. Bull.,37, No. 5, 1249–1255 (1989).
K. Ukawa, E. Imamiya, H. Yamamoto, et al., Ibid., No. 12, 3277–3285.
D. S. Vallari, Z. L. Smith, and F. Shyder, Biochem. Biophys. Res. Commun.,156, No. 1, 1–8 (1988).
D. S. Vallari, M. Record, Z. L. Smith, and F. Snyder, Biochim. Biophys. Acta,1006, No. 2, 250–254 (1989).
W. J. Van Blitterswijk, H. Hilkmann, and G. A. Storme, Lipids,22, No. 11, 820–823 (1987).
W. J. Van Blitterswijk, R. Van der Bend, I. M. Kramer, et al., Ibid., pp. 842–846.
W. R. Vogler, A. C. Olson, S. Okamoto, and L. B. Somberg, Ibid., pp. 919–924.
N. Weber, Progress in Biochemical Pharmacology. Vol. 22: Biologically Active Lipids, K. K. Carroll, ed., Basel (1988), pp. 48–57.
R. W. Wildox, R. L. Wykle, J. D. Schmitt, and L. W. Daniel, Lipids,22, No. 11, 800–807 (1987).
B. Zheng, K. Oishi, K. Shoji, et al., Cancer Res.,50, No. 10, 3025–3031 (1990).
Author information
Authors and Affiliations
Additional information
Translated from Khimiko-farmatsevticheskii Zhurnal, Vol. 27, No. 6, pp. 3–13, June, 1993.
Rights and permissions
About this article
Cite this article
Sablina, M.A., Ushakova, I.P. & Serebrennikova, G.A. Lipids with an ether bond in oncology (review). Pharm Chem J 27, 363–377 (1993). https://doi.org/10.1007/BF00780652
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00780652